Streptomyces isolates: Difference between revisions
CSV import |
CSV import |
||
| Line 35: | Line 35: | ||
[[Category:Pharmaceutical industry]] | [[Category:Pharmaceutical industry]] | ||
{{pharmacology-stub}} | {{pharmacology-stub}} | ||
<gallery> | |||
File:Doxorubicin–DNA_complex_1D12.png|Doxorubicin–DNA complex | |||
File:Domain_organization_of_PKS_of_rapamycin_and_biosynthetic_intermediates.svg|Domain organization of PKS of rapamycin | |||
File:Anthracycline_aglycone_biosyn1.png|Anthracycline aglycone biosynthesis | |||
File:E-rhod_to_doxorubicin_biosynthesis222.png|E-rhod to doxorubicin biosynthesis | |||
</gallery> | |||
Latest revision as of 04:56, 18 February 2025
Streptomyces isolates are a genus of Actinobacteria, known for their distinct "earthy" odor that results from production of a volatile metabolite, geosmin. Streptomyces are characteristically aerobic and gram-positive, forming complex mycelial colonies, similar to fungi, with spores. They are prolific producers of antibiotics, and over two-thirds of naturally derived antibiotics are isolated from Streptomyces bacteria.
Taxonomy and Morphology[edit]
The genus Streptomyces includes over 500 species, making it the largest genus of Actinobacteria. Morphologically, Streptomyces species share common features with both bacteria and fungi. They form a complex mycelial colony, which differentiates into a network of branching hyphae. The hyphae further differentiate into long chains of spores, which are often pigmented and can be readily observed under a microscope.
Metabolism and Growth[edit]
Streptomyces species are obligate aerobes, and they exhibit a complex life cycle involving the formation of vegetative hyphae and aerial hyphae. The vegetative hyphae are responsible for growth and reproduction, while the aerial hyphae are involved in spore formation. Streptomyces species are also known for their ability to metabolize a wide range of organic compounds, including complex polysaccharides, lignin, and xenobiotic compounds.
Antibiotic Production[edit]
Streptomyces are best known for their ability to produce a wide range of bioactive compounds, including many antibiotics. These include streptomycin, the first antibiotic cure for tuberculosis, and numerous other antibiotics that are in common use today. The production of these antibiotics is often regulated by a complex network of genetic and environmental factors.
Biotechnological Applications[edit]
Due to their metabolic versatility and ability to produce a wide range of bioactive compounds, Streptomyces species have significant biotechnological potential. They are widely used in the pharmaceutical industry for the production of antibiotics, antifungals, antivirals, antitumor drugs, immunosuppressants, and enzymes. They are also used in the agricultural industry for the production of biopesticides and bioherbicides.
See Also[edit]
References[edit]
<references />
-
Doxorubicin–DNA complex
-
Domain organization of PKS of rapamycin
-
Anthracycline aglycone biosynthesis
-
E-rhod to doxorubicin biosynthesis
